Commonwealth Equity Services, LLC Infla Rx N.V. Transaction History
Commonwealth Equity Services, LLC
- $68.4 Billion
- Q4 2024
A detailed history of Commonwealth Equity Services, LLC transactions in Infla Rx N.V. stock. As of the latest transaction made, Commonwealth Equity Services, LLC holds 111,500 shares of IFRX stock, worth $223,000. This represents 0.0% of its overall portfolio holdings.
Number of Shares
111,500
Previous 92,500
20.54%
Holding current value
$223,000
Previous $142,000
93.66%
% of portfolio
0.0%
Previous 0.0%
Shares
10 transactions
Others Institutions Holding IFRX
# of Institutions
34Shares Held
12.9MCall Options Held
19.3KPut Options Held
0-
Suvretta Capital Management, LLC New York, NY5.73MShares$11.5 Million0.59% of portfolio
-
683 Capital Management, LLC New York, NY2.07MShares$4.14 Million0.37% of portfolio
-
Morgan Stanley New York, NY2.04MShares$4.08 Million0.0% of portfolio
-
Northern Trust Corp Chicago, IL667KShares$1.33 Million0.0% of portfolio
-
Raymond James Financial Inc St. Petersburg, FL638KShares$1.28 Million0.0% of portfolio
About InflaRx N.V.
- Ticker IFRX
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 44,203,800
- Market Cap $88.4M
- Description
- InflaRx N.V., a clinical-stage biopharmaceutical company, discovers and develops inhibitors using C5a technology primarily in Germany and the United States. The company's C5a is an inflammatory mediator that is involved in the progression of a variety of autoimmune and other inflammatory diseases. Its lead product candidate is vilobelimab, a nov...